HEALTH: Summary of Nov 5, 2026

By · Published on

Illustration of paramedics wheeling a stretcher towards an ambulance
AI-generated illustration; does not depict the actual event.

Today’s health summary covers a British health worker with Ebola being flown home from Congo, new vaccine candidates added to the Ebola trial there, an estimate of the lives a potassium-enriched salt could save, a sixth measles death in Pennsylvania and a global report on neglected tropical diseases.

British health worker with Ebola is flown home from Congo for treatment

A British health worker who tested positive for Ebola in the Democratic Republic of Congo is being evacuated to Britain for specialist treatment, the first British national infected in the current outbreak. The patient, sent to Congo by a humanitarian organisation to help with the response, was in a stable condition and was due to arrive on Wednesday or Thursday before being taken by specialist ambulance to a unit for high-consequence infectious diseases.

The British government said the risk to the public remained low and that established procedures had been activated, and officials did not expect disruption to travel or trade. Britain has recorded only four confirmed Ebola cases since 1976, none of them fatal. Several other Europeans have been infected in this outbreak, including a French doctor in June. With more than 10,000 confirmed cases, Congo’s epidemic ranks as the second largest ever recorded.

Ebola is a severe viral disease that spreads through direct contact with the bodily fluids of an infected person, and the World Health Organization says it kills about half of those infected on average. The viruses have caused intermittent outbreaks in sub-Saharan Africa since the disease was first reported in 1976, the largest being the West African epidemic of 2013–16. The current outbreak is caused by the Bundibugyo strain, which has no approved vaccine.


WHO adds two Bundibugyo vaccine candidates to its Ebola trial in Congo

The World Health Organization on Wednesday approved the addition of two new vaccine candidates to a clinical trial in the Democratic Republic of Congo, where an Ebola outbreak caused by the Bundibugyo virus has killed more than 5,300 people. Both candidates were designed for that strain: one comes from the University of Oxford working with India’s Serum Institute, the other from Moderna. Results are expected in early 2027.

The WHO’s Director-General, Tedros Adhanom Ghebreyesus, said a trial begun last month uses Ervebo, a vaccine approved for the Zaire strain but not for Bundibugyo, and that vaccines cannot replace early care, contact tracing, isolation and safe burials. Africa’s disease control agency has confirmed 10,444 cases, with a fatality rate above 50 per cent. Nigeria and Kenya have also recorded cases, and Tedros urged countries to lift travel restrictions.

Bundibugyo virus is closely related to the Zaire ebolavirus and is one of several viruses that cause Ebola disease in humans. It takes its name from Bundibugyo in western Uganda, where it was first discovered, and it caused outbreaks in 2007 and 2012 before the current one, which has become the fastest-growing Ebola outbreak on record. It is classed among the most dangerous pathogens, requiring the highest level of laboratory containment.


Potassium-enriched salt could prevent millions of deaths, researchers estimate

Swapping ordinary table salt for a substitute enriched with potassium could avert nearly three million deaths a year worldwide, along with 10 million annual cases of heart, circulation and kidney disease, according to an analysis by the George Institute for Global Health. The substitute looks and tastes like regular salt and costs between $6 and $20 in shops and online. The World Health Organization endorsed it last year. Potassium lowers blood pressure and helps the heart beat regularly.

Bruce Neal, a senior fellow at the institute, said too much sodium and too little potassium are well-established causes of high blood pressure, and that switching addresses both at once. He said wide change would be needed in the food industry, since more than 70 per cent of salt intake in Europe and North America comes from processed and restaurant food. People with serious kidney disease or taking certain medicines need precautions because of the risk of high potassium levels.

Salt substitutes usually replace part of the sodium chloride with potassium chloride. A 2021 trial involving 20,995 older people in China found that five years of cooking at home with such a substitute cut stroke risk by 14%, lowered major heart and circulation events by 13% and reduced deaths from any cause by 12%, compared with regular salt. A 2022 review of 26 trials found that substitutes probably lower blood pressure slightly and reduce some heart and stroke outcomes.


Pennsylvania confirms a sixth measles death as the state’s cases reach 1,467

An unvaccinated resident of Jefferson County, Pennsylvania, has died after testing positive for measles, the sixth measles-associated death confirmed in the state this year. The state Department of Health reported 34 more confirmed cases since Monday, bringing the total for 2026 to 1,467. Lancaster County, the centre of the outbreak, has now passed 500 cases and stands at 504, and more than a third of the state’s cases have been recorded there.

The health department also added Butler County to the list of places where residents have caught measles, meaning cases have now been recorded in 45 of Pennsylvania’s 67 counties this year. Before this latest death, the state had recorded three measles-associated deaths in Lancaster County and two in other counties. Community leaders have said the official figures are an undercount, because many people who catch measles never see a doctor.

Lancaster County, home to the largest Amish population in the United States, has been the epicentre of the country’s worst measles outbreak in 35 years. Vaccination rates are lower among Amish and conservative Mennonite communities, and they are also falling among the general public, although some residents have shown a new openness to vaccines. Measles is a highly contagious disease that a safe and effective vaccine prevents, and it was declared eliminated from the country in 2000.


WHO reports progress against neglected tropical diseases but warns gains are fragile

The World Health Organization said on Wednesday that 63 countries had eliminated at least one neglected tropical disease by June 2026, up from 42 at the end of 2020. Its global report, a midterm review of a road map running to 2030, found that the number of people needing treatment fell to 1.41 billion in 2024, down 36% since 2010. Sleeping sickness cases have dropped by 98% since 1999, and Guinea worm reached 10 human cases in 2025.

The report also found uneven progress. Dengue reached a record 15.1 million cases in 2024, deaths from diseases spread by insects have risen, and efforts to eradicate yaws are off track. Funding for these diseases remains 30% below levels seen before Covid-19, and a few donors provided nearly 80% of international aid between 2018 and 2024. Tedros Adhanom Ghebreyesus urged countries to increase domestic funding and build the services into primary care.

Neglected tropical diseases are a group of infections caused by viruses, bacteria, parasites and other pathogens that mainly affect poor communities in Africa, Asia and the Americas. They receive less attention and research money than HIV, tuberculosis and malaria, although some treatments are cheap. The road map aims by 2030 to cut by 90% the number of people needing treatment and to have 100 countries eliminate at least one of the diseases.

In this topic